LP220249-9
Ledipasvir
Active
Description
Ledipasvir is a hepatitis C virus (HCV) NS5A inhibiting antiviral drug for the treatment of HCV. It is used in combination with sofosbuvir, and approved by the FDA for the treatment of chronic hepatitis C genotype 1 infection in adults. PMID: 26788571 Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Ledipasvir
- Part Display Name
- Ledipasvir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-06-24
- Construct for LOINC Short Name
- Ledipasvir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 雷迪帕韦 Synonyms: GS 588; |
| es-ES | Spanish (Spain) | Ledipasvir |
| it-IT | Italian (Italy) | Ledipasvir |
| nl-NL | Dutch (Netherlands) | ledipasvir |
| fr-FR | French (France) | Ledipasvir |
| pl-PL | Polish (Poland) | Ledipaswir |
| el-GR | Greek (Greece) | Λεντιπασβίρη Synonyms: Λεντιπασβίρη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://